TCL was part of the trial team that recently secured a $475 million antitrust verdict against the
TCL Helps Secure Jury Verdict Resulting in $1.4 Billion in Class Relief Read More »
News
TCL currently represents a class of end payors (for example, insurers) in a recently settled antitrust suit against the makers of Tracleer, a blockbuster heart medication. In that case—Government Employees Health Association v. Actelion Pharmaceuticals Ltd., 18- cv-3560 (D. Md.)—the plaintiffs alleged that the defendants refused to provide Tracleer samples to generic-drug manufacturers. This in
Tracleer Settlement Receives Preliminary Approval Read More »
TCL recently settled a class action against the baby-food manufacturer, Gerber Products Co. The plaintiffs accused Gerber of falsely claiming that one of its infant formulas could reduce a child’s risk of developing allergies, and that Gerber used this false claim to inflate the formula’s price. TCL represented a class of New York and Florida
TCL Obtains Settlement for Class of Baby-Formula Purchasers Read More »